Increased caffeine consumption is associated with reduced hepatic fibrosis - Wikidata - wikimedia - TriplyDB

Increased caffeine consumption is associated with reduced hepatic fibrosis

Increased caffeine consumption is associated with reduced hepatic fibrosis

http://www.wikidata.org/entity/Q33572385

about

Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis Epidemiology of viral hepatitis and hepatocellular carcinoma Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.Current status of novel antifibrotic therapies in patients with chronic liver disease Coffee: The magical bean for liver diseases.Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Coffee consumption and risk of cancers: a meta-analysis of cohort studies.Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.Caffeine, a drug for all seasons.Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies.Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort Insulin resistance and chronic liver disease.Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine.Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis.Coffee consumption and NAFLD: a community based study on 1223 subjects.Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.Coffee and Liver Disease Epidemiology of hepatocellular carcinoma: consider the population.The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers A 90-Day Oral Toxicological Evaluation of the Methylurate Purine Alkaloid Theacrine Coffee and liver - long way to go.Interaction between hepatitis C virus and metabolic factors.Pathophysiology of NASH: perspectives for a targeted treatment.Evolving challenges in hepatic fibrosis.New therapeutic paradigm for patients with cirrhosis.Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.Impact of coffee on liver diseases: a systematic review.Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Natural history of HCV infection.

P2860

Q26740559-A29296D6-A06E-46C1-BCB1-7775CA9577F4 Q26771518-44EA49AA-3DC2-4B3D-8E6C-DC7219AF0F37 Q26771874-529D5417-D537-43AC-AD67-67EAC28174D1 Q29617918-A835CCBC-6626-4FF0-9170-452370A019A0 Q30429470-870C6A58-A131-4083-8F5F-6398D3DBA633 Q30457852-140E78EF-A706-4E3E-9246-E035DFA98DAA Q30473375-D85B5DCF-76A4-4620-AFD4-73B18AC85F4E Q33716189-4A9E0F2C-EF54-4085-AFD9-7788F2BD10D0 Q33812148-4E9D5FA1-CF6F-4AC9-BBE0-9FD1022F91DC Q33846685-B13B4765-C6F8-45CD-AD46-BB3D182ACCFC Q33911547-27D2FCBB-668D-4180-9E5E-DDF4E3E6BE62 Q33938555-45F86FE5-59AE-4874-A491-84E9AB9B57BF Q33946576-1EC78F9C-6FBF-4CE8-AD36-C3914F85CBFB Q34717498-52082022-B418-4E02-AAF4-A5DDBDA5C6DC Q34758930-D978CCD0-A9B7-4328-B057-76D0A308A0C2 Q35073012-D0F4BA3B-05DA-43B2-B637-F2CB8D707C8C Q35079069-A66915DD-8608-460A-87FE-B1DD6E8B9CEB Q35135195-F3947059-6BC2-4D9C-933D-AB4C4B2E6889 Q35490295-9E33F4BF-66CC-4644-BD7B-2992AE7153BD Q35560040-232DEC7A-2C32-483D-9883-EAE7241000DB Q35831047-CEADC302-86FF-46A0-B9DC-E6975EF36777 Q35837908-D133953F-C16C-4A1E-9366-72FB89F6A3CE Q36060366-EBF8C89A-F9AF-4200-B518-830986118C70 Q36173424-0F09EF02-4902-4A63-BE8A-1DE7CAD71BEF Q36289486-2CCF4A89-9D6E-42C7-AE6C-FDCDA6830DB5 Q36886788-8A381F2C-D86B-4922-A08E-1CC21FDC6798 Q36930514-F68AB2DF-D632-49D9-8B23-41465BC4ED1E Q37185740-FEEE7430-C67B-425C-A671-A953D693EF94 Q37231754-3BB80138-1C86-4E9C-B24E-61E16B3FC1C7 Q37613528-FE697A09-AE1A-4E7C-841C-4CC489145784 Q37654443-3F4A2EF0-8473-463D-923C-C066E79B72FE Q37699476-ED17E15D-8EE0-4323-88AE-0332FC06CDF5 Q37768335-90BDF4E0-A232-42C3-A32D-0D1F77EF2781 Q38021413-7FF943D4-14D2-4ED9-A034-118D111A4B3F Q38071416-06980348-B4D9-48CB-B898-29D161D34314 Q38150457-19EB1A15-2827-47C6-B829-52534F0B1239 Q38160948-92D4536A-EB3E-43F9-B92A-A023F84C25B6 Q38166445-AFD4904E-E4A7-4B62-8638-080470A70091 Q38261875-B912A42C-C7B7-4492-AC4C-C692724DCD26 Q38552179-75BFC115-F736-4F6F-B8E4-025593DCAACD

P2860

Increased caffeine consumption is associated with reduced hepatic fibrosis

http://www.wikidata.org/entity/Q33572385

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Increased caffeine consumption is associated with reduced hepatic fibrosis

@ast

Increased caffeine consumption is associated with reduced hepatic fibrosis

@en

Increased caffeine consumption is associated with reduced hepatic fibrosis.

@nl

type

label

Increased caffeine consumption is associated with reduced hepatic fibrosis

@ast

Increased caffeine consumption is associated with reduced hepatic fibrosis

@en

Increased caffeine consumption is associated with reduced hepatic fibrosis.

@nl

prefLabel

Increased caffeine consumption is associated with reduced hepatic fibrosis

@ast

Increased caffeine consumption is associated with reduced hepatic fibrosis

@en

Increased caffeine consumption is associated with reduced hepatic fibrosis.

@nl

P1433

Q33572385-D86CB018-B993-4D9A-B1F8-9C1B0EF79FE9

P1476

Q33572385-6CA3BD0B-FF91-45FC-B7DB-6B711633D0D2

P2093

Q33572385-13A3248D-4D89-420F-A521-B3C83F48194D

Q33572385-5889792C-69C2-4521-9DDB-663861EDAA0A

Q33572385-CF114938-5B0E-4BB4-B81A-7A078C50C654

Q33572385-D68DAB53-1384-4167-9EC5-EF44AFDC09D2

Q33572385-DAEF432C-FCB1-4C79-A4BF-591050CC1AF2

Q33572385-E0D23B06-3216-4F1C-AA2E-D68CAE1B64D0

P2860

Q33572385-056DEE66-B8F2-44A1-A243-E2E36D5FF03D

Q33572385-0F0C8EBA-3733-407D-8B10-68B98F2CAC97

Q33572385-13A071F8-D017-472F-B9CA-8C0935F15401

Q33572385-24BDA00B-5B36-4337-A398-7520C7EAE129

Q33572385-2C25F973-AAED-4BE3-9652-A690F595F9DD

Q33572385-2EAB3172-F0C9-4EBC-8EE2-899CEE5C3B53

Q33572385-2F78C069-8494-4369-B2B7-2A3E098A3773

Q33572385-3267F9EB-1317-4E3C-BD1D-A4A05FAAB4A1

Q33572385-67325720-77B4-4521-9BA1-CB238BBCC894

Q33572385-71EA0135-FE7C-4D79-AE55-583D412D9744

P304

Q33572385-8A204F22-AFAE-4DA8-8A18-CD754E97098A

P31

Q33572385-DED203BE-6781-40EF-83EB-7AA248594565

P356

Q33572385-1D48BF55-A62F-4044-81C7-68D64FEBC2FE

P407

Q33572385-5F137F55-73ED-418A-9959-A17F0FB64D48

P433

Q33572385-CEB29A12-D4CE-48DF-A250-C071FAC9EDE0

P478

Q33572385-F5B22D4B-579B-4212-889D-8276B4B787B1

P50

Q33572385-0160655D-BBEE-4ED9-ACD0-9892E1A0767A

P577

Q33572385-24E7BCED-D292-4064-9D32-4ECD12F8DC0A

P5875

Q33572385-59129727-5949-4D29-B42D-1B5299BFAE4D

P698

Q33572385-F77F235C-7B2D-45AA-BC75-C04EDF8A2F15

P932

Q33572385-8217F831-3F36-4AEB-B590-94531B35AB65

P356

P1433

P1476

Increased caffeine consumption is associated with reduced hepatic fibrosis

@en

P2093

Apurva A Modi

http://www.w3.org/2001/XMLSchema#string

James E Everhart

http://www.w3.org/2001/XMLSchema#string

Jay H Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Jordan J Feld

http://www.w3.org/2001/XMLSchema#string

T Jake Liang

http://www.w3.org/2001/XMLSchema#string

Yoon Park

http://www.w3.org/2001/XMLSchema#string

P2860

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

Coffee, cirrhosis, and transaminase enzymes

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study

Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways

Histological grading and staging of chronic hepatitis

Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.

Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.

Does coffee protect against hepatocellular carcinoma?

The relationship of coffee consumption with mortality.

Caffeine consumption.

P304

201-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23279

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

David E. Kleiner

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40769479

http://www.w3.org/2001/XMLSchema#string

P698

20034049

http://www.w3.org/2001/XMLSchema#string

P932

2801884

http://www.w3.org/2001/XMLSchema#string